Primary Job Title CEO Primary Organization Clal Biotechnology Industries
Location Tel Aviv, Israel, Asia Regions Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) Gender Male
LinkedIn View on LinkedIn
Ofer Gonen is the Chief Executive Officer of Clal Biotechnology Industries.He Previously worked at Cactus Acquisition Corp as the Chief Executive Officer.Ofer Gonen attended Tel Aviv University in 1996. Ofer Gonen is the Chief Executive Officer of Clal Biotechnology Industries Ltd. (TASE: CBI) and Cactus Acquisition Corp. 1 (Nasdaq: CCTS). Mr.
Gonen has more than 20 years of experience in managing life science investments and business collaborations in both the US and Israel. Mr. Gonen serves as a board member of several private and publicly-traded portfolio companies of CBI, including Gamida Cell (Nasdaq: GMDA), MediWound (Nasdaq: MDWD) and Cactus (Nasdaq: CCTS), as well as a managing partner at the Anatomy Medical Fund. Before joining CBI, Mr. Gonen was the General Manager of Biomedical Investments Ltd., a partner at Arte Venture Group, as well as a technology consultant to various Israeli venture capital funds.
Mr. Gonen gained extensive experience in R&D and management of defense-oriented projects at the prestigious “Talpiot” program of the Israeli Defense Forces. He holds a B.Sc. in Physics, Mathematics and Chemistry from the Hebrew University of Jerusalem, and an M.A. in Economics and Finance from Tel Aviv University, with distinction.
